Showing posts with label Blogging. Show all posts
Showing posts with label Blogging. Show all posts

Friday, October 10, 2014

A Blogger’s Dilemma – What To Do About `Suspect’ Ebola Cases

image

 

# 9173

 

Over the past 48 hours I’m aware of perhaps a dozen suspected Ebola `scares’ around the world (outside of Western Africa) where one or more persons has displayed symptoms consistent with the disease – resulting in hospitalization and/or testing.

 

Recent locations have included Paris, Macedonia, Texas,  Brazil, and  Prague.

 

I’ve not blogged any of these cases because:

  • Most, I believe, will turn out to be false alarms
  • They are already well covered  by the media and Flublogia (Crofsblog, FluTrackers, the Flu Wiki)
  • And realistically, there is little of value I can add beyond saying `We’ll have to wait to see’.

 

As I written before, whenever surveillance (whether for Ebola, Avian Flu, or MERS) works – we tend to see a lot of `suspect cases’ – although the vast majority will turn out to have something far less concerning – like seasonal flu, rhinovirus, or malaria.  

 

This fall and winter  – we’ve not only Ebola to screen for, it’s a fair bet we’ll see the return of MERS and avian flu – meaning that the number of `suspect cases’  in the news only likely to rise even further. 

 

If I tried to blog on each one of these reports, soon I’d have time for little else. None of this is a pledge that I won’t cover suspect cases – only that I feel I need more of a reason than `it has been reported somewhere in the world that . . . – before I’ll  write about it. 

 

If it is an extraordinarily unusual or potentially high-impact report, then yes, I may blog it.  And If I can add context, or additional value – then once again, I’ll probably include it. 

 

It’s a personal choice, but I’ll leave the reporting of individual suspect cases to those who do that sort of thing much better than I, and try to concentrate on more macro infectious disease and preparedness issues, to which I can hopefully add some value.

Saturday, August 11, 2012

CIDRAP: Children & Middle-Aged Most Susceptible To H3N2v

image

Credit Wikipedia

 

# 6489

 


Robert Roos of CIDRAP has an excellent report on a study – published on Aug 7th in The Journal of Infectious Diseases – that looks at pre-existing, and vaccine-induced immunity to the emerging H3N2v swine flu virus by age cohorts.

 

This serological study, conducted in Canada, is called :

 

Cross-reactive and vaccine-induced antibody to emerging swine influenza A(H3N2)v

Danuta M. Skowronski, Naveed Z. Janjua, Gaston De Serres3, Dale Purych, Vladimir Gilca, David W. Scheifele, Marc Dionne, Suzana Sabaiduc, Jennifer L. Gardy, Guiyun Li, Nathalie Bastien, Martin Petric, Guy Boivin and Yan Li

 

 

Below is Robert’s report on these findings, and as I’m hardly likely to improve upon his work, I’ll simply invite you to follow the link below and read:

 

Study: Children, middle-aged most vulnerable to variant H3N2

Robert Roos * News Editor

Aug 10, 2012 (CIDRAP News) – A serologic study from Canada suggests that children and middle-aged adults have little or no immunity to the swine-origin variant H3N2 influenza virus (H3N2v), but about half of adolescents and young adults have some degree of immunity as measured by antibody levels.

(Continue . . .)

 


Robert’s story mentioned earlier studies with similar findings, and you can find details on them in these earlier blogs:

 

Last April in MMWR: Antibodies Cross-Reactive to Influenza A (H3N2) Variant Virus, we saw a study that found that children under the age of ten were practically devoid of antibodies to this virus, and were likely the most susceptible to infection.

 

A few months before, in Eurosurveillance: Older People May Be Susceptible To The H3N2v Virus), we saw evidence that the moderate levels of immunity detected in adolescent and young adult populations declined with age.

 

In other H3N2v news, Lisa Schnirring of CIDRAP has a excellent roundup, including the release of new interim clinician guidelines, the poor reliability of RIDTs (Rapid Influenza Detection Tests) with this virus, and an age breakdown of confirmed cases that now includes 10 adults.

 

CDC updates novel H3N2 info for clinicians

Lisa Schnirring * Staff Writer

Aug 10, 2012 (CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) today reported that it has received 153 reports of novel H3N2 infections (H3N2v) since illnesses started surfacing in the middle of July, nearly all of them in people who had contact with pigs or were around pigs at fairs.

 

In another development, the CDC issued new information on H3N2v for clinicians, including an evaluation of rapid influenza tests that found their sensitivity varies greatly, and the agency urged clinicians not to use negative results as the basis for treatment.

(Continue . . . )

 

 

A blogger’s Note:

 

The slow emergence of this swine H3N2v virus into the human population is a fascinating story, and one that certainly deserves ongoing coverage.  But at the same time, the last thing this story needs is unwarranted hype.

 

According to the CDC, this virus has not adapted well enough to human physiology to spark a pandemic.  Nearly all confirmed cases appear to be the result of direct contact with an infected pig.

 

Sustained and efficient Human-to-Human transmission does not appear to be occurring at this time.

 

The caveat being, that over time, that could change.

 

For now, this virus is less a public health threat story and more an opportunity for us to learn how these types of viruses evolve in swine and (on rare occasion) seep into the human population.

 

A cautionary tale, if you will, on how nature’s laboratory is open 24/7 - constantly trying out new viral combinations - looking for an evolutionary advantage.

 

The dilemma, from my standpoint, is how to cover this story responsibly. 

 

Rather than rush to post a blog every time we get an updated case count, for my own sanity, I’ve decided only to blog on the H3N2v virus when there is something more substantial to report.

 

This weekend I’ll explore the possibility of keeping a daily update `State Confirmed H3N2v Cases’ in my sidebar, at least until that becomes too unwieldy.

 

Even so, I’m sure H3N2v will get ample attention in these pages.

 

As we wait to see what this H3N2v virus ends up doing - between seasonal flu, bird flu, swine flu, seal flu, and bat flu, plus non-flu related stories - I’m confident there will be no shortage of topics to blog about.

Thursday, July 08, 2010

Solidarity For Science Bloggers

 

 

# 4708

 

UPDATED:   According to PZ Myers on his Pharyngula blog the powers-that-be at Scienceblogs have reversed course (see PepsiCo has been expelled).

 

Not everyone who left is likely to return, however.  David Dobbs makes his case for staying away in Why I’m Staying Gone from ScienceBlogs.

 

 

 

Although I’m not on Scienceblogs, a lot of my favorite blogs (and bloggers) are . . . or were, anyway.  So the sad goings on over at that blog portal are of great interest to me, and no doubt to my readers as well.

 

Two days ago the news broke that the managers of Scienceblogs had `sold’ Pepsi Cola a blog slot on that prestigious venue.  

 

This was billed as a corporate sponsored blog, called Food Frontiers, that was to highlight the work being done in the nutritional field by PepsiCo researchers.

 

In other words, thinly veiled PR (public relations) and indirect advertisement.

 

And, as Maryn McKenna so aptly put it in her blog, `a crapstorm ensued’.

Although many of the resident Sciblings have weighed in on this controversy, I’ll refer you to the postings of two of personal favorites; David Dobbs and Maryn McKenna.

 

A food blog I can’t digest  -  Neruon Culture

Pepsi: Messy  - Superbug

 

Maryn has since suspended blogging on Sciblogs pending the resolution of this mess. A number of other science bloggers have done likewise, or have left the site entirely. 

 

Some of the media coverage includes Carl Zimmer’s blog on Discover  Oh, Pepsi, What Hast Thou Wrought? and a scathing assessment in the UK’s Guardian ScienceBlogs, we have a problem.

 

While blogging is generally thought of as `free’, it doesn’t come without significant personal cost to the authors. To be done well, and consistently, requires an inordinate investment of time, effort, and usually money.

 

And most bloggers never see a dime in return.

 

It takes years of steady blogging to develop a loyal following and a reputation. So moving away from Scienceblogs isn’t something to be done lightly.

 

It involves not only a lot of effort to move posts and setup shop elsewhere, it also entails the considerable risk that some of your regular readers might not manage to follow you to your new home.

 

So the decision to exit isn’t an easy one.

 

Nor is the decision to go on hiatus, as many readers will fall out of the habit of checking for updates.

 

 

To help loyal readers along, Chris Clarke on his Coyote Crossing blog has a very useful ScienceBlogs Diaspora RSS feed post, which should help those with RSS feed readers to follow their favorite bloggers wherever they land.

 

Carl Zimmer at the Discover Blog, The Loom, is also keeping a list of ex-pat Sciblings and where they end up.

 

If you are a regular reader of these excellent blogs, please take the time to follow and bookmark their new homes.  

 

And if you don’t already know these blogs, now is a great time to explore their varied offerings. 

 

You will not only be expanding your horizons, you will be showing solidarity for these science bloggers.

 

I’m still hoping for some resolution to this fiasco that doesn’t involve the continued exodus of talent from Scienceblogs.  But right now, the prospects appear dim.

 

Whether a good science blog remains at Scienceblogs, or sets up shop elsewhere, they deserve your support and attention. 

 

There is far too much drek and pseudo-science online posing as `fact’ and `truth’, so those sites that take evidence-based science seriously should be treasured.

 

I’ll update this story in the future, but your best source of information on it will be from the ex-pat bloggers who are now setting up shop elsewhere.

Tuesday, March 02, 2010

Tip-Toeing Through The Minefield

 

 

# 4398

 

 

There was a sardonic one-liner back in the 1970s, after a decade of media `scare stories’ about the dangers of everything from butter, to coffee, to artificial sweeteners, that said; `Face it . . everything gives lab rats cancer’.

 

While probably not true, it sprang to mind this morning when I saw this little tidbit that appears into a recent edition of PNAS.

 

“Control” laboratory rodents are metabolically morbid: Why it matters

  1. Bronwen Martin, Sunggoan Ji, Stuart Maudsley, and Mark P. Mattson

Abstract

Failure to recognize that many standard control rats and mice used in biomedical research are sedentary, obese, glucose intolerant, and on a trajectory to premature death may confound data interpretation and outcomes of human studies. Fundamental aspects of cellular physiology, vulnerability to oxidative stress, inflammation, and associated diseases are among the many biological processes affected by dietary energy intake and exercise.

 

Although overfed sedentary rodents may be reasonable models for the study of obesity in humans, treatments shown to be efficacious in these animal models may prove ineffective or exhibit novel side effects in active, normal-weight subjects.

 

I suppose the good news here is that with the proliferation of fast food, Playstations, a ubiquitous Internet, and 500 cable channels streaming into every home – soon mankind’s metabolism will match that of lab rats and it will all balance out.

 


Scientific experimentation with lab rats isn’t wrong, you see. It is just a little ahead of its time.

 

I am, admittedly, always a little bit skeptical when I read the conclusions of the latest whiz-bang scientific study or a press release announcing an exciting new advance in medicine.  Even the ones that don’t employ rodents.

 

Not because I harbor conspiratorial beliefs, or a deep suspicion of the motives of scientists . . . but because I view scientific discovery as a journey  . . . not a destination.

 

Advances in science are anything but linear, and very often we find ourselves sidetracked or detoured down some flawed alley of investigation along the way.   

 

What was conventional scientific wisdom five years ago may be debunked today, and what we replace that old knowledge with now may be obsoleted in short order as well.

 

Absolutes in science are hard to find.  And the process of determining scientific `fact’ can be messy and prolonged.

 

Which is why you’ll often see cautions in my blogs about the latest research, and an avoidance of self-serving `medical miracle’ press releases about innovations that may never get out of the laboratory.

 

Over the past year, I’ve highlighted some of the conflicting studies on the efficacy of face masks vs. respirators for infection control, on the usefulness of hand washing as a flu preventative, and numerous studies on exactly how influenza is transmitted.

 

If you are looking for a consensus among scientists on these matters, I’m afraid you’ll have to keep looking.

 

What you probably can find, however, is a study that will support practically any scientific, personal, religious or economic bias or agenda you might happen to favor. 

 

And barring that, you can most certainly find a study that conveniently questions the methods of any study you might oppose. 

 

It’s a contrarian’s delight.

 

Scientific research can be a bit of a minefield through which one must tread carefully.  But rather than being distressed by the confusion or ambiguity that conflicting research sometimes promotes, I’m intrigued by it. 

 

 

Which is why I try to put links to the original study (or abstract) whenever I write about a journal article, so that the reader can look beyond the press release or the media hype and hopefully weigh the merits of the research themselves. 

 

As a non-scientist, I also rely heavily on the opinions and reviews of reputable scientists and (science) journalists whom I trust for guidance, particularly in those areas where I have little or no expertise.  

 


Although it usually comes at a great price, pandemics . . .  like wars, often result in a significant surge in scientific and medical knowledge.   

 

Our understanding of how influenza mutates, evolves, and spreads will no doubt grow tremendously over the next couple of years as the data gathered during this pandemic is examined and analyzed. 

 

While I try to highlight only reputable studies, the admonition of Caveat Lector remains for anything you read here (or anyplace else for that matter).   

 

Novel H1N1 has already re-written much of what we thought we knew about influenza virology. And some of the things we will think we learned from this virus may be overturned by the next pathogen to come down the pike. 

 

That’s simply the nature of science.   Our knowledge, like the influenza virus, is constantly evolving.  

 

Which is why, after more than 4400 essays in this space, there will always be something new to write about tomorrow.